Cargando…
Proteome and Network Analysis Provides Novel Insights Into Developing and Established Chemotherapy-Induced Peripheral Neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating side-effect of cancer therapies. So far, the development of CIPN cannot be prevented, neither can established CIPN be reverted, often leading to the cessation of necessary chemotherapy. Thus, there is an urgent need to explore the m...
Autores principales: | de Clauser, Larissa, Kappert, Christin, Sondermann, Julia R., Gomez-Varela, David, Flatters, Sarah J. L., Schmidt, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895144/ https://www.ncbi.nlm.nih.gov/pubmed/35250568 http://dx.doi.org/10.3389/fphar.2022.818690 |
Ejemplares similares
-
Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
por: Han, Yaqin, et al.
Publicado: (2013) -
Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A meta-Analysis
por: Chen, Jie, et al.
Publicado: (2021) -
Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials
por: Wang, Chenkun, et al.
Publicado: (2022) -
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
por: Kerckhove, Nicolas, et al.
Publicado: (2021) -
Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy
por: Yamamoto, Shota, et al.
Publicado: (2021)